Absorption kinetics of hydroflumethiazide

Journal of Clinical Pharmacology
P J McNamaraM Gibaldi

Abstract

The pharmacokinetics of hydroflumethiazide after oral administration of a 100-mg dose to 12 volunteers were evaluated to determine whether absorption of the drug is best described by zero-order or first-order absorption. Comparison of the two absorption models was based on three criteria: (1) correlation coefficients; (2) standard deviations of the parameter estimates; and (3) visual fits. Evaluation of the individual results in light of each criterion showed that the zero-order absorption model is the more appropriate one for describing the hydroflumethiazide data.

References

Jan 1, 1977·Journal of Clinical Pharmacology·G J YakatanJ T Doluisio
Apr 1, 1977·Journal of Clinical Pharmacology·P G WellingG L Amidon
Oct 1, 1977·Journal of Clinical Pharmacology·W A ColburnM Gibaldi
May 1, 1970·The American Journal of Digestive Diseases·A R Cooke

Citations

Sep 1, 1979·European Journal of Clinical Pharmacology·O Brørs, S Jacobsen
Mar 18, 2003·Journal of Clinical Pharmacology·Honghui Zhou
Nov 1, 1986·Biopharmaceutics & Drug Disposition·P G Welling
Jan 1, 1982·Biopharmaceutics & Drug Disposition·M C MeyerK Rotenberg
Oct 1, 1979·Journal of Pharmacokinetics and Biopharmaceutics·M EhrneboL O Boréus
Aug 1, 1988·Journal of Pharmacokinetics and Biopharmaceutics·J P ReymondW Niederberger
Feb 1, 1990·Journal of Pharmacokinetics and Biopharmaceutics·B G ReignerT N Tozer

Related Concepts

Diucardin
Intestinal Absorption

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Lipidomics & Rhinovirus Infection

Lipidomics can be used to examine the lipid species involved with pathogenic conditions, such as viral associated inflammation. Discovered the latest research on Lipidomics & Rhinovirus Infection.

Spatio-Temporal Regulation of DNA Repair

DNA repair is a complex process regulated by several different classes of enzymes, including ligases, endonucleases, and polymerases. This feed focuses on the spatial and temporal regulation that accompanies DNA damage signaling and repair enzymes and processes.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Torsion Dystonia

Torsion dystonia is a movement disorder characterized by loss of control of voluntary movements appearing as sustained muscle contractions and/or abnormal postures. Here is the latest research.

Archaeal RNA Polymerase

Archaeal RNA polymerases are most similar to eukaryotic RNA polymerase II but require the support of only two archaeal general transcription factors, TBP (TATA-box binding protein) and TFB (archaeal homologue of the eukaryotic general transcription factor TFIIB) to initiate basal transcription. Here is the latest research on archaeal RNA polymerases.

Alzheimer's Disease: MS4A

Variants within the membrane-spanning 4-domains subfamily A (MS4A) gene cluster have recently been implicated in Alzheimer's disease in genome-wide association studies. Here is the latest research on Alzheimer's disease and MS4A.

Central Pontine Myelinolysis

Central Pontine Myelinolysis is a neurologic disorder caused most frequently by rapid correction of hyponatremia and is characterized by demyelination that affects the central portion of the base of the pons. Here is the latest research on this disease.